hydroxychloroquine has been researched along with pilocarpine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Adyanthaya, RS; Akpek, EK; Baer, AN; Lindsley, KB; McDonnell, PJ; Swamy, R | 1 |
| Kim, E; Koh, JH; Kweon, SM; Lee, HN; Lee, SG; Shin, HJ; So, MW; Young Choi, H | 1 |
| Alvarado-Franco, NL; Femat-Roldan, G; Garza-Alpirez, A; Gonzalez-Marques, C; Martinez-Ramirez, D; Olguín-Ramírez, LA | 1 |
| Chen, CH; Chou, YC; Huang, WY; Ju, UH; Kao, CH; Lin, CL; Lin, CS; Lin, KT; Lin, TY; Liu, FC; Shen, CH; Yang, TY | 1 |
2 review(s) available for hydroxychloroquine and pilocarpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Dry Eye Syndromes; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lubricants; Pilocarpine; Quinuclidines; Sjogren's Syndrome; Thiophenes | 2011 |
3 other study(ies) available for hydroxychloroquine and pilocarpine
| Article | Year |
|---|---|
Primary Sjogren syndrome diagnosed simultaneously with localized amyloidosis of the lacrimal gland: A case report.
Topics: Amyloidosis; Antirheumatic Agents; Biopsy; Female; Humans; Hydroxychloroquine; Lacrimal Apparatus; Magnetic Resonance Imaging; Middle Aged; Miotics; Pilocarpine; Rare Diseases; Salivary Glands, Minor; Sjogren's Syndrome; Treatment Outcome | 2018 |
Athetoid Movements as Initial Manifestation of Primary Sjögren Syndrome.
Topics: Aged; Amines; Anticonvulsants; Athetosis; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxychloroquine; Movement Disorders; Muscarinic Agonists; Pilocarpine; Sjogren's Syndrome | 2018 |
Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Comorbidity; Female; Humans; Hydroxychloroquine; Immunosuppression Therapy; Incidence; Male; Methylprednisolone; Middle Aged; Muscarinic Agonists; National Health Programs; Parkinson Disease; Pilocarpine; Quinuclidines; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Taiwan; Thiophenes | 2019 |